Security key
63009J107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 3,520,885
- Total 13F value
- $28,772,000
- Share change
- -573,224
- SEC-reported price per share
- $8.10
- Number of holders
- 7
- Value change
- -$6,268,938
- Number of sells
- 5
- Shares outstanding
- 46,821,220
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
7
Top holders
7
NBTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63009J107
Recent filing periods:
Ownership snapshot
Top reported holders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
9/9
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 3%
Showing 1-6 of 9 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 3%.
9 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 5
BAILLIE GIFFORD & CO
3%
PERCEPTIVE ADVISORS LLC
2.3%
Artal Group S.A.
2.1%
ORBIMED ADVISORS LLC
1.1%
UBS Group AG
0.13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 9 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
Company
|
3%
|
$15,862,000
1,400,000 shares
|
— | 30 Sep 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2.3%
|
$12,039,000
1,059,800 shares
|
— | 30 Sep 2021 |
| Artal Group S.A. |
13F
Company
|
2.1%
|
$11,360,000
1,000,000 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.1%
|
$5,680,000
500,000 shares
|
— | 30 Sep 2021 |
| UBS Group AG |
13F
Company
|
0.13%
|
$686,000
60,353 shares
|
— | 30 Sep 2021 |
| Woodline Partners LP |
13F
Company
|
0.11%
|
$587,000
51,635 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
3,520,885
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
9
Q4 2021 holders
7
Holder diff
-2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend